Advanced Parkinson's Disease Clinical Trials

21 clinical trials for Advanced Parkinson's Disease across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa — RECRUITING
• SAD Study in Patients With Parkinson's Disease and Motor Fluctuations — RECRUITING · PHASE1
• Prospective comparison of clinical versus anatomically informed CONtact selECTion in subthalamic deep brain stimulation for Parkinson’s Disease — RECRUITING
• The effect of amantadine as add-on therapy for motor fluctuations in advanced Parkinson’s disease: a randomized double-blinded placebo-controlled trial — TERMINATED · PHASE2
• Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease — COMPLETED · PHASE1
• An Automated Navigation System for Deep Brain Electrode Implantation — OTHER
• A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease — OTHER · PHASE1
• A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD) — COMPLETED · PHASE3
• Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease — COMPLETED · PHASE3
• A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease — COMPLETED · PHASE2
• Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease — COMPLETED
• A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease — COMPLETED · PHASE3
• An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications — COMPLETED · PHASE3
• A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications — COMPLETED · PHASE3
• Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease — COMPLETED · PHASE2
• Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects — COMPLETED · PHASE3
• Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects — COMPLETED · PHASE3
• Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease — COMPLETED · PHASE3
• Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction — TERMINATED · PHASE3
• A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease — COMPLETED · PHASE3
• Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease — OTHER · NA

Refine this search